Sensei Biotherapeutics, Inc. (SNSE) Stock Overview
Explore Sensei Biotherapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Sensei Biotherapeutics, Inc. (SNSE)
Key Financials
Key Financials
Market Cap
18.6M
P/E Ratio
-0.09
EPS (TTM)
$-142.72
ROE
-1.93%
SNSE Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Sensei Biotherapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SNSE on the NASDAQ shows an RSI of 79.09, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $25.54 for the NASDAQ listing.
Key metrics behind Sensei Biotherapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.09 and a market capitalization of 18.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SNSE on the NASDAQ.